Toronto, ON – May 1, 2015
GreenSky is happy to announce our engagement by Cyclica Inc. to raise its next round of capital and to act as a long term partner in its future fund raising efforts.
Cyclica is focused on using integrated big data and applied analytics techniques to increase productivity in pharmaceutical research and development. Ligand Express™ models the dynamic state of proteins, enabling the discovery of protein-drug interactions that existing approaches will typically miss. With the ability to quickly and efficiently predict a drug’s interactions with the human body, clients and partners have access to quality data and in-depth reports for anticipating risks and making informed R&D investment decisions. Cyclica is streamlining the drug discovery process, making medicinces safer for everyone.